Mesoblast (ASX:MSB) share price soars after exciting June quarter update
Jaz Harrison
July 18, 2025
The Mesoblast Ltd (ASX:MSB) share price is currently up 27%
Mesoblast Ltd (ASX:MSB) is a leader in providing allogeneic (off the shelf) cellular medicines. It owns a portfolio of late-stage product candidates with three product candidates in Phase 3 trials, being acute graft versus host disease, chronic heart failure and chronic low back pain due to degenerative disc disease. The company has facilities in Melbourne, New York, Singapore and Texas and is listed on the ASX and the NASDAQ.
The Mesoblast Ltd (ASX:MSB) share price is currently up 27%
S&P 500 and Nasdaq rebound 9% and 11% respectively. Australian
Here’s today’s The Match Out report from Market Matters’ James
Here’s today’s latest market update by Drew Meredith, CFP, from
Here’s today’s The Match Out report from Market Matters’ James
The S&P/ASX 200 (INDEXASX: XJO) Index rose 8.3 points, or
Here’s today’s The Match Out report from Market Matters’ James
Here’s today’s latest updates on the S&P/ASX 200 (INDEXASX: XJO)
Here’s today’s The Match Out report from Market Matters’ James
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.